Biopharmaceutical manufacturer and commercializer with neuroscience focus
Tris Pharma is a mid-sized biopharmaceutical company built around branded and generic product commercialization plus a pipeline of proprietary medicines. The hiring mix is skewed toward manufacturing and field roles (sales + medical), with concurrent investments in regulatory compliance and network infrastructure—a pattern consistent with a company scaling commercialization while managing the operational complexity of multi-site pharma operations.
Notable leadership hires: Procurement Director, Medical Director, Marketing Director
Tris Pharma develops and commercializes biopharmaceutical products, with particular strength in neuroscience therapeutics. The company holds over 150 U.S. and international patents. It operates across two main footprints: a New Jersey headquarters housing roughly two-thirds of its ~500-person workforce, and a distributed field organization spanning the U.S. The portfolio includes both branded and generic products sold domestically, with licensed products in international markets. Current initiatives span Phase IV clinical trials, supply-chain continuity, regulatory reporting, and expansion into ADHD treatment categories.
Tris uses analytical chemistry and QA tools including HPLC, gas chromatography, ICP-MS, and atomic absorption spectroscopy. IT infrastructure includes Cisco networking, Windows, DNS/DHCP, and GCP.
Monmouth Junction, New Jersey, where approximately two-thirds of the ~500-person workforce operates. The remaining third work in field roles across the United States.
Other companies in the same industry, closest in size